KFDA orders sales suspension for Novartis' famvir cream

Published: 2007-07-30 06:56:00

Updated: 2007-07-30 06:56:00

The government said on July 25 that it banned the sales of Novartis Korea's Famvir (famciclovir) and Dongyang Pharm's cimetiidne and famotidine for six months on grounds of their failure to submit related documents for this year's drug re-evaluation program.

The Korea Food and Drug Administrat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK